GeneOne Life Science, Inc. (KRX:011000)

South Korea · Delayed Price · Currency is KRW

2,670.00

-215.00 (-7.45%)

Sep 6, 2026, 3:08 AM KST

GeneOne Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	48,420	166,908	168,840	222,271	553,651	1,250,928
Market Cap Growth	-77.97%	-1.14%	-24.04%	-59.85%	-55.74%	30.16%
Enterprise Value	76,847	194,585	188,532	219,584	509,945	1,241,186
Last Close Price	2670.00	9795.00	10575.00	14200.00	35700.00	81000.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	3.92	7.24	4.73	5.53	11.36	32.32
PB Ratio	1.36	4.08	1.97	1.99	3.05	6.06
P/TBV Ratio	1.37	4.10	1.98	2.00	3.06	6.08

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6.21	8.44	5.28	5.46	10.47	32.07

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.98	0.81	0.32	0.15	0.11	0.09
Net Debt / Equity Ratio	0.82	0.76	0.30	0.06	-0.14	-0.43
Net Debt / EBITDA Ratio	-1.17	-1.21	-1.01	-0.20	0.75	3.89
Net Debt / FCF Ratio	-2.19	-1.88	-1.31	-0.26	0.37	1.02
Asset Turnover	0.10	0.17	0.24	0.22	0.21	0.20
Inventory Turnover	2.13	2.56	2.97	3.23	3.10	3.17
Quick Ratio	0.14	0.07	0.24	0.77	1.66	3.36
Current Ratio	0.38	0.36	0.67	1.51	2.16	3.87
Return on Equity (ROE)	-99.68%	-81.98%	-49.25%	-53.09%	-19.67%	-10.42%
Return on Assets (ROA)	-20.90%	-20.35%	-17.79%	-16.17%	-10.61%	-8.88%
Return on Capital Employed (ROCE)	-66.80%	-67.30%	-39.50%	-37.70%	-21.30%	-12.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-101.07%	-31.07%	-28.75%	-34.99%	-6.89%	-1.27%
FCF Yield	-27.45%	-9.93%	-11.46%	-12.30%	-12.54%	-6.98%
Buyback Yield / Dilution	61.22%	-3.82%	-2.17%	-0.34%	-4.37%	-22.98%